BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $791,000 | -14.8% | 12,317 | +3.0% | 0.38% | -1.0% |
| Q1 2022 | $928,000 | -9.8% | 11,962 | -0.2% | 0.39% | +2.7% |
| Q4 2021 | $1,029,000 | +3.0% | 11,986 | -3.5% | 0.38% | -7.1% |
| Q3 2021 | $999,000 | +4.3% | 12,422 | +4.4% | 0.41% | -1.9% |
| Q2 2021 | $958,000 | -2.7% | 11,895 | +1.9% | 0.41% | -14.5% |
| Q1 2021 | $985,000 | +4.9% | 11,678 | -0.2% | 0.48% | -6.9% |
| Q4 2020 | $939,000 | -52.6% | 11,699 | -52.6% | 0.52% | -57.8% |
| Q3 2020 | $1,983,000 | -5.1% | 24,664 | +1.6% | 1.23% | -14.6% |
| Q2 2020 | $2,089,000 | -10.2% | 24,264 | -15.3% | 1.44% | -25.8% |
| Q1 2020 | $2,327,000 | -5.1% | 28,661 | -2.2% | 1.94% | +9.4% |
| Q4 2019 | $2,451,000 | -5.1% | 29,317 | -0.7% | 1.77% | -19.4% |
| Q3 2019 | $2,582,000 | +7.3% | 29,518 | +0.5% | 2.20% | +27.3% |
| Q2 2019 | $2,406,000 | +2.6% | 29,375 | +1.8% | 1.73% | -4.6% |
| Q1 2019 | $2,346,000 | -9.4% | 28,849 | -26.6% | 1.81% | -23.1% |
| Q4 2018 | $2,589,000 | -21.0% | 39,330 | -7.5% | 2.36% | -4.4% |
| Q3 2018 | $3,279,000 | +63.1% | 42,533 | +56.2% | 2.47% | +50.5% |
| Q2 2018 | $2,011,000 | +77.7% | 27,237 | +56.6% | 1.64% | +71.6% |
| Q1 2018 | $1,132,000 | +26.5% | 17,398 | +25.6% | 0.96% | +14.0% |
| Q4 2017 | $895,000 | – | 13,853 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |